2022.02.16
Osaka (Japan), February 16, 2022 – Interprotein Corporation and SPERA PHARMA, Inc. today hereby announce that we have signed an agreement for comprehensive collaboration aiming at research & development, manufacturing and commercialization of novel small molecule and peptide pharmaceuticals for various diseases with high unmet medical needs.
Please refer to this link for details.
page top